None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. age 19 over 2. Patients with vasculitis (American College of Rheumatology or International Chapel Hill Consensus Conference) granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), polyarteritis nodosa, and polyarthritis (EGPA), Polyarteritis nodosa and Takayasu arteritis 3. Patients who understood the agreement and agreed to participate in the study
Exclusion criteria
Exclusion criteria: 1. Under 19 years 2. Pregnancy, lactation 3. Patients with vasculitis that can not be categorized as the diagnosis or classified as other vasculitis 4. Patients who do not agree with the study and those who can not read the consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall patient survival rate;Rate of disease flare up;Treatment response rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes of BVAS;VDI score;Quality of life | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital